Netherlands· NL-197e30a47c50
Brimica Genuair 340 microgram/12 microgram, inhalatiepoeder
A formoterol und aclidinium bromid product containing aclidiniumbromide + formoterolfumaraat 2-water, registered in Netherlands by Covis Pharma Europe B.V.. The same ATC class is registered in 10 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Formoterol und aclidinium bromid is registered in 10 of 19 countries.
Countries holding a registration under ATC R03AL05 (formoterol und aclidinium bromid), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 6 of them publish a price we can compare per daily dose
Formoterol und aclidinium bromid · ATC R03AL05
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- ACLIDINIUMBROMIDE + FORMOTEROLFUMARAAT 2-WATER
- Manufacturer
- Covis Pharma Europe B.V.
- Country
- Netherlands (NL)
- ATC code
- R03AL05
- ATC class
- Formoterol und Aclidinium bromid
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/14/963
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Formoterol und aclidinium bromid in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBRIMICA GENUAIRCovis Pharma Europe B.V., Amsterdam
- SpainBRIMICA GENUAIR 340 MICROGRAMOS/12 MICROGRAMOS POLVO PARA INHALACIONCovis Pharma Europe B.V.
- SwedenBrimica Genuair 340 mikrogram/12 mikrogram InhalationspulverCovis Pharma Europe B.V.
- United KingdomAclidinium bromide 396micrograms/dose / Formoterol 11.8micrograms/dose dry powder inhalerColorama Pharmaceuticals Ltd
- IcelandBrimica GenuairCovis Pharma Europe B.V.
- FinlandBrimica GenuairCOVIS PHARMA EUROPE B.V.
- PolandBrimica GenuairCovis Pharma Europe B.V.
- United StatesDUAKLIR PRESSAIRCovis Pharma US, Inc
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Brimica Genuair, Duaklir Genuair
- Liechtenstein · Brimica Genuair, Duaklir Genuair
- Norway · Brimica Genuair, Duaklir Genuair
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/795c14b8-abfc-4997-9ef9-3d232b416d79 GET /v1/drugs/795c14b8-abfc-4997-9ef9-3d232b416d79?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Inhalatiepoeder",
"route": "Inhalatie",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/brimica-genuair-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Formoterol and aclidinium bromide",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp115191",
"excipients": [
"LACTOSE 1-WATER"
],
"substances": [
"ACLIDINIUMBROMIDE",
"FORMOTEROLFUMARAAT 2-WATER"
],
"leaflet_url": null,
"authorised_at": "2014/11/19",
"procedure_number": "EMEA/H/C/003969",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/14/963",
"additional_monitoring": "N"
}See everything about formoterol und aclidinium bromid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.